
Oluwatimilehin Ayodeji John
Oluwatimilehin Ayodeji John is a dedicated health and medical journalist at Flobstar covering public health emergencies, epidemiological surveillance, clinical breakthroughs, and global healthcare policy. His reporting focuses on translating complex biomedical research and institutional public health data into clear, evidence-based journalism.
Reporting by O. Ayodeji John
300 Articles
British Healthcare Worker Infected With Ebola to Be Evacuated From DR Congo to UK
The healthcare worker is in stable condition and will receive specialist treatment in Britain, while authorities say the risk to the wider public remains low.

WHO Recommends Two New Ebola Vaccine Candidates for Clinical Trial in DR Congo
The vaccines, developed by Oxford and Moderna, are designed to target the Bundibugyo virus responsible for the ongoing outbreak.

Japanese scientists develop cancer targeting drug system using tumor carbon monoxide
Scientists create method to convert cancer cells' own carbon monoxide into targeted anticancer drugs

Global adolescent inactivity crisis shows 15 year stagnation
New WHO data shows 15 years of stagnation in adolescent physical activity

63 Countries Have Eliminated at Least One Neglected Tropical Disease, WHO Reports
WHO report reveals uneven progress against neglected tropical diseases, with financing gaps and climate change threatening 2030 targets.

Anthrax outbreak kills 30 hippos in Congo amid Ebola, cholera crises
At least 30 hippos die from anthrax in Congo’s Virunga National Park as authorities monitor risks to humans amid overlapping outbreaks.

Ancient fish may explain why human brains control opposite sides of the body
New research suggests brain's cross-wiring originated over 500 million years ago in visual systems of ancient fish

Climate finance for poorer nations lags behind urgent needs
UN report reveals adaptation finance for poor nations stalled despite rising climate crisis impacts

Gene therapy promises lifelong disease protection but raises long term safety risks
Gene therapy may offer lifelong protection against heart disease and cholesterol but experts warn of unknown long-term risks.
